Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#91 / 200 Total
SKYH - Sky Harbour Group Corporation - Stock Price Chart
TickerSKYH [AMEX]
CompanySky Harbour Group Corporation
CountryUSA
IndustryAerospace & Defense
Market Cap292.86MEPS (ttm)-1.10
P/E-EPS this Y81.63%
Forward P/E-EPS next Y52.78%
PEG-EPS past 5Y-
P/S38.64EPS next 5Y-
P/B4.16EPS Q/Q-1840.34%
Dividend-Sales Q/Q267.49%
Insider Own55.48%Inst Own42.78%
Insider Trans0.00%Inst Trans-16.11%
Short Float1.75%EarningsMar 27/a
Analyst Recom1.00Target Price16.00
Avg Volume26.61K52W Range4.15 - 13.60
Mar-28-24 05:31AM Sky Harbour Group Corp (SKYH) Releases 2023 Financial Results and Strategic Updates (GuruFocus.com)
Mar-27-24 05:00PM Sky Harbour Group Corporation Announces its 2023 Financial Results; Updates on New Ground Leases, Construction and Hangar Leasing; Injects Equity into Obligated Group and Files Various Registration Statements with SEC (Business Wire)
Mar-26-24 05:49PM Sky Harbour to Report 2023 Full Year Results and Host Webcast Investor Call Tomorrow, March 27, 2024 (Business Wire)
Jan-03-24 05:10PM Sky Harbour Announces Incoming Chief Operating Officer, New Manufacturing Leadership, and an Update on Construction Budget at Dallas-Addison Airport (Business Wire)
Dec-18-23 05:17PM Sky Harbour Announces Two New Developments Aimed at Serving the New York and Connecticut Business Aviation Markets and Provides an Update on Construction Activities (Business Wire)
Nov-29-23 04:01PM Sky Harbour Group Announces the Second Closing of its Private Equity Placement with an Altai Capital Investment Vehicle for an Additional Aggregate Consideration of $15,000,000 (Business Wire) +13.93%
Nov-09-23 09:40PM Sky Harbour Group Corporation Announces its Q3 2023 Financial Results and Updates on Leasing, Construction and New Ground Lease Activities (Business Wire) +6.47%
Nov-02-23 06:07PM Sky Harbour Group Announces an Agreement and Closing of a Sale of 6,586,154 Shares of Class A Common Stock and 1,141,600 Warrants in a Private Equity Placement with Altai Capital Investment Vehicles for Aggregate Consideration of $42,810,000 (Business Wire)
Oct-12-23 08:23AM Chicago Executive Airport Announces Sky Harbour Hangar Campus Development (Business Wire) +6.07%
Oct-10-23 08:27PM Sky Harbour Group Corporation Announces Amendment to its 2023 Q2 Cash Flow Statement in Form 10-Q/A (Business Wire)
Sky Harbour Group Corp. engages in the development and leasing of general aviation hangars. It offers home-based solutions for business aircraft. The company was founded by Tal Keinan in October 2017 and is headquartered in White Plains, NY.
GRWG - GrowGeneration Corp - Stock Price Chart
TickerGRWG [NASD, RUT]
CompanyGrowGeneration Corp
CountryUSA
IndustrySpecialty Retail
Market Cap183.31MEPS (ttm)-0.76
P/E-EPS this Y53.01%
Forward P/E-EPS next Y40.64%
PEG-EPS past 5Y-28.61%
P/S0.81EPS next 5Y20.00%
P/B1.06EPS Q/Q-81.26%
Dividend-Sales Q/Q-9.19%
Insider Own7.08%Inst Own36.63%
Insider Trans27.01%Inst Trans-1.87%
Short Float7.39%EarningsMay 08/a
Analyst Recom2.14Target Price3.77
Avg Volume1.37M52W Range1.77 - 5.00
GrowGeneration Corp. engages in the development, marketing, retail, and distribution of hydroponic products and services. It operates through the following segments: Cultivating and Gardening, Storage Solutions, and Corporate. The Cultivating and Gardening segment includes hydroponic and organic gardening business. The Storage Solutions segment involves benching and racking. The company was founded by Darren Lampert and Michael S. Salaman on March 6, 2014 and is headquartered in Greenwood Village, CO.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Salaman MichaelPresidentNov 15 '23Buy2.35302,766710,1381,240,075Nov 16 04:29 PM
Lampert DarrenCEONov 15 '23Buy2.3621,00049,6381,333,120Nov 15 06:37 PM
Lampert DarrenCEONov 14 '23Buy2.11175,000368,8301,312,120Nov 15 06:37 PM
Salaman MichaelPresidentNov 14 '23Buy2.15127,234272,968937,309Nov 16 04:29 PM
Lampert DarrenCEONov 13 '23Buy1.92300,000575,4001,137,120Nov 15 06:37 PM
APM - Aptorum Group Ltd - Stock Price Chart
TickerAPM [NASD]
CompanyAptorum Group Ltd
CountryUnited Kingdom
IndustryBiotechnology
Market Cap25.90MEPS (ttm)-0.91
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y34.83%
P/S60.23EPS next 5Y-
P/B1.04EPS Q/Q123.18%
Dividend-Sales Q/Q-100.00%
Insider Own58.20%Inst Own0.85%
Insider Trans0.00%Inst Trans346.64%
Short Float1.89%EarningsDec 22/a
Analyst Recom1.00Target Price80.00
Avg Volume2.45M52W Range1.35 - 17.49
Aptorum Group Ltd. is a pharmaceutical company, which engages in the discovery, development, and commercializing of therapeutic assets to treat diseases with unmet medical needs. It operates through the Therapeutics and Non-Therapeutics segments. The Therapeutics segment seeks to develop drug molecules and certain technologies for the treatment and diagnosis of human disease conditions. The Non-Therapeutics segment encompasses diagnostics projects including a novel molecular-based rapid pathogen identification and detection diagnostics, AML Clinic, and sale of natural supplements. Its pipeline include Smart-Act, Acticule, RPIDD, Nativus, and Claves series. The company was founded by Ian Huen on September 13, 2010 and is headquartered in London, the United Kingdom.
TRVI - Trevi Therapeutics Inc - Stock Price Chart
TickerTRVI [NASD, RUT]
CompanyTrevi Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap206.39MEPS (ttm)-0.34
P/E-EPS this Y-44.83%
Forward P/E-EPS next Y-10.00%
PEG-EPS past 5Y27.24%
P/S-EPS next 5Y-
P/B2.79EPS Q/Q-68.88%
Dividend-Sales Q/Q-
Insider Own33.43%Inst Own41.16%
Insider Trans0.00%Inst Trans43.28%
Short Float1.92%EarningsMay 07/a
Analyst Recom1.00Target Price7.40
Avg Volume299.99K52W Range0.97 - 4.00
Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good in March 2011 and is headquartered in New Haven, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Delfini LisaChief Financial OfficerOct 11 '23Option Exercise0.512,2921,17136,686Oct 12 04:00 PM
Delfini LisaChief Financial OfficerOct 11 '23Sale2.027851,58635,901Oct 12 04:00 PM
Delfini LisaChief Financial OfficerSep 11 '23Option Exercise0.512,2911,17135,105Sep 13 04:06 PM
Delfini LisaChief Financial OfficerSep 11 '23Sale2.207111,56434,394Sep 13 04:06 PM
Delfini LisaChief Financial OfficerAug 11 '23Option Exercise0.512,2921,17133,496Aug 14 04:00 PM
LESL - Leslies Inc - Stock Price Chart
TickerLESL [NASD, RUT]
CompanyLeslies Inc
CountryUSA
IndustrySpecialty Retail
Market Cap960.37MEPS (ttm)0.08
P/E64.90EPS this Y3.30%
Forward P/E12.86EPS next Y39.89%
PEG6.69EPS past 5Y9.95%
P/S0.68EPS next 5Y9.70%
P/B-EPS Q/Q-9.09%
Dividend-Sales Q/Q-11.36%
Insider Own4.66%Inst Own114.68%
Insider Trans0.00%Inst Trans8.53%
Short Float11.05%EarningsMay 08/a
Analyst Recom2.69Target Price6.56
Avg Volume3.46M52W Range3.79 - 11.68
Leslie's, Inc. engages in the provision of direct-to-consumer pool and spa care services. It offers equipment installation and repair for residential consumers and professional pool operators. The company was founded in 1963 and is headquartered in Phoenix, AZ.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Daniel YolandaDirectorMar 14 '24Option Exercise0.0010,357026,015Mar 15 04:15 PM
Ortega Steven LDirectorMar 14 '24Option Exercise0.0010,3570373,494Mar 15 04:15 PM
KUFEL ERIC JDirectorMar 14 '24Option Exercise0.0010,357010,357Mar 15 04:15 PM
OFarrell Susan CDirectorMar 14 '24Option Exercise0.0010,357026,015Mar 15 04:15 PM
Strain JohnDirectorMar 14 '24Option Exercise0.0010,357088,678Mar 15 04:15 PM
ADPT - Adaptive Biotechnologies Corp - Stock Price Chart
TickerADPT [NASD, RUT]
CompanyAdaptive Biotechnologies Corp
CountryUSA
IndustryBiotechnology
Market Cap519.48MEPS (ttm)-1.48
P/E-EPS this Y16.51%
Forward P/E-EPS next Y15.64%
PEG-EPS past 5Y-32.91%
P/S2.98EPS next 5Y21.60%
P/B1.89EPS Q/Q18.93%
Dividend-Sales Q/Q11.23%
Insider Own4.54%Inst Own92.11%
Insider Trans-2.64%Inst Trans-3.04%
Short Float7.11%EarningsMay 07/a
Analyst Recom1.50Target Price6.67
Avg Volume1.75M52W Range2.28 - 9.08
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson on September 8, 2009 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NEUPERT PETER MDirectorMar 12 '24Option Exercise0.8415,00012,600169,296Mar 13 05:55 PM
ROBINS CHAD MCEO and ChairmanMar 05 '24Sale3.4348,673167,0072,576,701Mar 06 07:40 PM
RUBINSTEIN JULIEPresidentMar 05 '24Sale3.4739,070135,764472,754Mar 06 07:41 PM
BENZENO SHARONChief Commercial Ofc Imm MedMar 05 '24Sale3.4429,390100,994327,415Mar 06 07:42 PM
PETERSON TYCHOChief Financial OfficerMar 05 '24Sale3.4415,45653,169531,553Mar 06 07:40 PM
EYPT - EyePoint Pharmaceuticals Inc - Stock Price Chart
TickerEYPT [NASD, RUT]
CompanyEyePoint Pharmaceuticals Inc
CountryUSA
IndustryBiotechnology
Market Cap667.14MEPS (ttm)-1.83
P/E-EPS this Y-25.00%
Forward P/E-EPS next Y-44.18%
PEG-EPS past 5Y29.57%
P/S13.34EPS next 5Y-
P/B2.36EPS Q/Q1.98%
Dividend-Sales Q/Q52.08%
Insider Own6.42%Inst Own94.86%
Insider Trans-28.33%Inst Trans-0.28%
Short Float13.41%EarningsMay 08/b
Analyst Recom1.20Target Price39.11
Avg Volume1.15M52W Range5.67 - 30.99
EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Cormorant Asset Management, LP10% OwnerMay 06 '24Buy11.86850,00010,081,7218,325,000May 08 04:23 PM
Cormorant Asset Management, LP10% OwnerApr 18 '24Buy18.03581,76510,489,4467,475,000Apr 22 04:00 PM
Paggiarino Dario A.Chief Medical OfficerMar 30 '24Option Exercise0.0050,404092,626Apr 02 05:27 PM
Duker Jay S.President and CEOFeb 09 '24Option Exercise0.0011,967055,453Feb 13 05:37 PM
Lurker NancyExecutive Vice ChairFeb 09 '24Option Exercise0.0037,5340172,975Feb 13 05:40 PM
SPB - Spectrum Brands Holdings Inc. - Stock Price Chart
TickerSPB [NYSE]
CompanySpectrum Brands Holdings Inc.
CountryUSA
IndustryHousehold & Personal Products
Market Cap2.83BEPS (ttm)45.78
P/E2.05EPS this Y159.62%
Forward P/E19.85EPS next Y18.77%
PEG0.11EPS past 5Y17.07%
P/S0.98EPS next 5Y18.20%
P/B1.25EPS Q/Q211.08%
Dividend1.80%Sales Q/Q-2.96%
Insider Own3.24%Inst Own101.91%
Insider Trans4.37%Inst Trans-6.19%
Short Float6.83%EarningsMay 09/b
Analyst Recom2.18Target Price92.79
Avg Volume339.42K52W Range65.27 - 89.64
Spectrum Brands Holdings, Inc. engages in the manufacture and supply of consumer products and home essentials. The firm operates through the following segments: Home and Personal Care (HPC), Global Pet Care (GPC), and Home and Garden (H&G). The GPC segment focuses on the pet care business. The H&G segment is involved in the home and garden, cleaning products, and insect control business. The HPC segment includes the small kitchen and personal care appliances business. The company was founded in 1906 and is headquartered in Middleton, WI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Maura David MExecutive Chairman and CEONov 28 '23Buy67.0320,0001,340,600764,391Nov 28 04:19 PM
Maura David MExecutive Chairman and CEONov 27 '23Buy66.4120,0001,328,100744,391Nov 28 04:19 PM
Zargar EhsanEVP, GC & Corporate SecretaryNov 27 '23Buy66.501,05370,024145,415Nov 28 04:21 PM
Maura David MExecutive Chairman and CEOAug 29 '23Buy82.895,000414,450693,816Aug 30 04:30 PM
Zargar EhsanEVP, GC & Corporate SecretaryAug 29 '23Buy82.9884369,952117,335Aug 30 04:31 PM
KW - Kennedy-Wilson Holdings Inc - Stock Price Chart
TickerKW [NYSE, RUT]
CompanyKennedy-Wilson Holdings Inc
CountryUSA
IndustryReal Estate Services
Market Cap1.37BEPS (ttm)-1.97
P/E-EPS this Y-3.25%
Forward P/E-EPS next Y55.12%
PEG-EPS past 5Y-
P/S2.42EPS next 5Y37.78%
P/B1.42EPS Q/Q165.58%
Dividend9.69%Sales Q/Q3.18%
Insider Own15.52%Inst Own89.30%
Insider Trans0.00%Inst Trans1.20%
Short Float6.67%EarningsMay 08/a
Analyst Recom3.50Target Price10.10
Avg Volume1.42M52W Range7.85 - 17.43
Kennedy-Wilson Holdings, Inc. operates as a real estate investment company, which engages in the ownership, operation, development, and investment in real estate properties. It operates through the Consolidated Portfolio and Co-Investment Portfolio segments. The Consolidated Portfolio segment includes the investments that the company has made in real estate and real estate-related assets. The Co-Investment Portfolio segment focuses on co-investments that the company has made in real estate and real estate related assets, including loans secured by real estate, through the co-mingled funds and joint ventures that it manages, as well as the fees that it earns on its fee bearing capital. The company was founded in 1977 and is headquartered in Beverly Hills, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
MCMORROW WILLIAM JCHAIRMAN AND CEONov 06 '23Buy12.32100,0001,232,0008,599,517Nov 06 05:53 PM
SMLR - Semler Scientific Inc - Stock Price Chart
TickerSMLR [NASD, RUT]
CompanySemler Scientific Inc
CountryUSA
IndustryMedical Devices
Market Cap163.31MEPS (ttm)2.78
P/E8.36EPS this Y-3.42%
Forward P/E-EPS next Y-
PEG-EPS past 5Y31.99%
P/S2.48EPS next 5Y-
P/B2.06EPS Q/Q23.95%
Dividend-Sales Q/Q-12.65%
Insider Own22.26%Inst Own51.35%
Insider Trans0.00%Inst Trans39.03%
Short Float4.52%EarningsMay 07/a
Analyst Recom1.00Target Price40.00
Avg Volume85.23K52W Range20.88 - 53.38
Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. Its multi-test service platform, WellChec, comprehensively evaluates its customers' patients for chronic disease, including heart attacks and strokes, using its QuantaFlo product as well as other tests. The company was founded by Herbert J. Semler, Guinasso Cindy and Shirley L. Semler on August 9, 2007 and is headquartered in Santa Clara, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SEMLER ERICDirectorSep 13 '23Buy28.1126,868755,25977,771Sep 13 07:05 PM
SEMLER ERICDirectorSep 12 '23Buy27.7025,903717,51350,903Sep 13 07:05 PM
SEMLER ERICDirectorSep 11 '23Buy26.9825,000674,50025,000Sep 13 07:05 PM
15678910111213141520